Acute amiodarone liver toxicity likely due to Ischemic hepatitis

Israel Medical Association Journal

Volumn 13, Issue 12, 2011, Pages 748-752

  Gluck, Nathan ^a,b   Fried, Mordechai ^b   Porat, Reuven ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amiodarone; Hepatotoxicity; Ischemic hepatitis; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FORWARD HEART FAILURE; HEART ARRHYTHMIA; HEPATITIS; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; HYPOTENSION; ISCHEMIC HEPATITIS; KIDNEY DISEASE; LIVER BIOPSY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDLINE; RETROSPECTIVE STUDY; SCORING SYSTEM; BIOPSY; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; LIVER; LIVER FUNCTION TEST; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; TOXIC HEPATITIS; VASCULARIZATION;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BIOPSY; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; ISCHEMIA; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84858060723     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pirovino M, Muller O, Zysset T, Honegger U. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model. Hepatology 1988; 8 (3): 591-598.
2. Lewis JH, Ranard RC, Caruso A, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989; 9 (5): 679-685.
3. Ratz Bravo AE, Drewe J, Schlienger RG, Krahenbuhl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med 2005, 33 (1): 128-134.
4. MacFadyen RJ, Palmer TJ, Hisamuddin K. Rapidly fatal acute amiodarone hepatitis occurring in the context of multiple organ failure. Int J Cardiol 2003; 91 (2/3): 245-247.
5. Maker AV, Orgill DP. Rapid acute amiodarone-induced hepatotoxicity in a burn patient. J Burn Care Rehabil 2005; 26 (4): 341-343.
6. Morelli S, Guido V, De Marzio P, Aguglia F, Balsano F. Early hepatitis during intravenous amiodarone administration. Cardiology 1991; 78 (3): 291-294.
7. Gregory SA, Webster JB, Chapman GD. Acute hepatitis induced by parenteral amiodarone. Am J Med 2002; 113 (3): 254-255.
8. Simon JP, Zannad F, Trechot P, Thisse JY, Houplon M, Aliot E. Acute hepatitis after a loading dose of intravenous amiodarone. Cardiovasc Drugs Ther (Int Soc Cardiovasc Pharmacother) 1990; 4 (6): 1467-1468.
9. Breuer HW, Bossek W, Haferland C, Schmidt M, Neumann H, Gruszka J. Amiodarone-induced severe hepatitis mediated by immunological mechanisms. Int J Clin Pharmacol Ther 1998; 36 (6): 350-352.
10. Rizzioli E, Incasa E, Gamberini S, et al. Acute toxic hepatitis after amiodarone intravenous loading. Am J Emerg Med 2007; 25 (9): 1082.
11. Lupon-Roses J, Simo-Canonge R, Lu-Cortez L, Permanyer-Miralda G, Allende-Monclus H. Probable early acute hepatitis with parenteral amiodarone. Clin Cardiol 1986; 9 (5): 223-225.
12. Kalantzis N, Gabriel P, Mouzas J, Tiniakos D, Tsigas D, Tiniakos G. Acute amiodarone-induced hepatitis. Hepatogastroenterology 1991; 38 (1): 71-74.
13. Gibson PR, Dudley FJ. Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust N Z J Med 1984; 14 (6): 822-825.
14. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999; 45 (1): 129-133.
15. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46 (11): 1323-1330.
16. Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010; 51 (6): 2117-2126.
17. James PR, Hardman SM. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy. Heart 1997; 77 (6): 583-584.
18. Arimone Y, Begaud B, Miremont-Salame G, et al. A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol 2006; 59 (3): 308-314.
19. Waters B, Riely CA. Drug- and chemical-induced liver disease. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology. 5th edn. Philadelphia: WB Saunders, 1995: 2172.
20. Chitturi S, Farrel GC. Drug Induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff 's Diseases of the Liver. 10th edn. Philadelphia: Lippincott-Williams & Wilkins, 2007: 952-953.
21. Barletta JF. Cardiopulmonary resuscitation. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 6th edn. New York: McGraw-Hill, 2005: 177-178.
22. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992; 87 (7): 831-836.
23. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109 (2): 109-113.
24. Henrion J, Colin L, Schapira M, Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997; 24 (4): 245-249.
25. Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology (Baltimore) 1999; 29 (2): 427-433.